These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 13585848)

  • 1. [Vegetative nervous system & coronary insufficiency; effect of mild insulin shock on functional coronary insufficiency].
    CUPPINI R; CAROTTI A
    Cuore Circ; 1958 Jun; 42(3):172-84. PubMed ID: 13585848
    [No Abstract]   [Full Text] [Related]  

  • 2. [The theoretical basis of arterenol therapy of shock, especially in coronary occlusion].
    NORREGAARD S; THAGE O
    Nord Med; 1956 Jun; 55(24):825-7. PubMed ID: 13348919
    [No Abstract]   [Full Text] [Related]  

  • 3. Experience with arterenol therapy of shock in a medical department, especially in coronary occlusion.
    THAGE O; NORREGAARD S
    Nord Med; 1956 Jun; 55(24):827-30. PubMed ID: 13348920
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metaraminol (aramine) therapy of shock due to coronary occlusion].
    MUNE O; NORREGAARD S
    Nord Med; 1959 Aug; 62():1255-60. PubMed ID: 14425245
    [No Abstract]   [Full Text] [Related]  

  • 5. Rapid cold plasma infusion treatment for severe shock (peripheral failure) following coronary occulsion.
    VOGELSANG A
    Can Med Assoc J; 1957 Aug; 77(3):232-4. PubMed ID: 13446808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Modification of functional lability of the visual analysor during therapy of coronary insufficiency].
    MATUSOVA AP
    Ter Arkh; 1956; 28(6):54-9. PubMed ID: 13391732
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined treatment of functional and organic coronary insufficiency].
    PRESCH HR
    Rev Pathol Gen Physiol Clin; 1954 Oct; 54(661):1189. PubMed ID: 14358150
    [No Abstract]   [Full Text] [Related]  

  • 8. Simvastatin for secondary prevention of all-cause mortality and major coronary events in patients with mild chronic renal insufficiency.
    Chonchol M; Cook T; Kjekshus J; Pedersen TR; Lindenfeld J
    Am J Kidney Dis; 2007 Mar; 49(3):373-82. PubMed ID: 17336698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Principles of therapy in coronary insufficiency].
    Klaus W
    Med Monatsschr Pharm; 1981 Sep; 4(9):257-62. PubMed ID: 7289968
    [No Abstract]   [Full Text] [Related]  

  • 10. Oxygen therapy of coronary insufficiency.
    BABENKO RA
    Tr Leningr Sanitarnogig Med Inst; 1958; 40():48-58. PubMed ID: 13603689
    [No Abstract]   [Full Text] [Related]  

  • 11. [Chloracizine therapy of patients with coronary insufficiency].
    ERINA EV
    Klin Med (Mosk); 1961 Jun; 39():95-100. PubMed ID: 13697164
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the therapy of coronary insufficiency as a secondary finding].
    SAHM F
    Med Klin; 1960 Aug; 55():1426-8. PubMed ID: 13745406
    [No Abstract]   [Full Text] [Related]  

  • 13. [Certain aspects of oxygen therapy of coronary insufficiency].
    MOLCHANOV NS
    Ter Arkh; 1958 Sep; 30(8):67-73. PubMed ID: 13603342
    [No Abstract]   [Full Text] [Related]  

  • 14. [The therapy of coronary insufficiency with mono-oxidase inhibitor].
    POPPE A; HOLLDACK K
    Verh Dtsch Ges Kreislaufforsch; 1960; 26():266-9. PubMed ID: 13737196
    [No Abstract]   [Full Text] [Related]  

  • 15. [The favorable effect of "Gangleron" in a case of marked coronary insufficiency].
    BACHA J; JEBEJIAN R
    Arch Mal Coeur Vaiss; 1960 Dec; 53():1418-22. PubMed ID: 13685630
    [No Abstract]   [Full Text] [Related]  

  • 16. [Result of intra-arterial novocaine therapy of coronary insufficiency].
    GORBADEI SA
    Tr Leningr Sanitarnogig Med Inst; 1957; 34():171-3. PubMed ID: 13468069
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy of hypertensive heart disease and coronary insufficiency with convallaria and hydroxypropyltheophylline].
    LUDES H; NAFZIGER H
    Munch Med Wochenschr; 1959 Jan; 101(2):87-90. PubMed ID: 13622591
    [No Abstract]   [Full Text] [Related]  

  • 18. [Observations on insulin metabolism in schizophrenic subjects at the end of an insulin shock therapy cycle].
    CORSINI G; ARDITO R; CERRI B; BECCHINI F
    Rass Fisiopatol Clin Ter; 1962; 34():655-69. PubMed ID: 14023177
    [No Abstract]   [Full Text] [Related]  

  • 19. [Persantin, a new substance for therapy of coronary insufficiency].
    JUNEMANN P
    Munch Med Wochenschr; 1959 Feb; 101(8):340-1. PubMed ID: 13644100
    [No Abstract]   [Full Text] [Related]  

  • 20. [The favorable effect of "Gangleron" in a case of severe coronary insufficiency. (Observation with follow-up of 13 months)].
    BACHA J; JEBEJIAN R
    Rev Med Moyen Orient; 1960; 17():572-8. PubMed ID: 13685631
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.